다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Brain research. Molecular brain research, v.84 no.1/2, 2000년, pp.135 - 140
Szot, Patricia (Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Administration Puget Sound Health Care System, Seattle, WA 98108, USA) , Leverenz, James B (Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Administration Puget Sound Health Care System, Seattle, WA 98108, USA) , Peskind, Elaine R (Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Administration Puget Sound Health Care System, Seattle, WA 98108, USA) , Kiyasu, Elizabeth (Department of Medicine, University of Washington, Seattle, WA 98195, USA) , Rohde, Kirsten (Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Administration Puget Sound Health Care System, Seattle, WA 98108, USA) , Miller, Margaret A (Department of Psychiatry and Behavioral Science, University of Washington, Seattle, WA 98195, USA) , Raskind, Murray A (Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Veterans Administration Puget Sound Health Care System, Seattle, WA 98108, USA)
AI-Helper
AbstractDespite the loss of locus coeruleus (LC) noradrenergic neurons in Alzheimer’s disease (AD), cerebrospinal fluid norepinephrine (NE) levels are normal or increased in AD. This paradox suggests compensatory upregulation of NE synthetic capacity or downregulation of the NE transporter (N...
1987
Neurology Bondareff 32 164 1982 10.1212/WNL.32.2.164 Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia
J. Comp. Neurol. Chan-Palay 287 373 1989 10.1002/cne.902870308 Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer’s type and in Parkinson’s disease with and without dementia and depression
Br. Med. J. Cross 282 93 1981 10.1136/bmj.282.6258.93 Reduced dopamine-β-hydroxylase activity in Alzheimer’s disease
J. Neurochem. Cubells 65 502 1995 10.1046/j.1471-4159.1995.65020502.x Differential in vivo regulation of mRNA encoding the norepinephrine transporter and tyrosine hydroxylase in rat adrenal medulla and locus ceruleus
Exp. Brain Res. Dyon-Laurent 96 203 1993 10.1007/BF00227100 Functional reorganization of the noradrenergic system after partial fornix section: a behavioral and autoradiographic study
Am. J. Psychiatry Elrod 154 25 1997 10.1176/ajp.154.1.25 Effects of Alzheimer’s disease severity on cerebrospinal fluid norepinephrine concentration
Brain Res. Bull. Fallon 9 295 1982 10.1016/0361-9230(82)90143-5 Monoamine innervation of the forebrain: collateralization
J. Psychiatr. Res. Folstein 12 189 1975 10.1016/0022-3956(75)90026-6 Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician
J. Comp. Neurol. Fritschy 321 421 1992 10.1002/cne.903210309 Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain
Ann. Neurol. German 32 667 1992 10.1002/ana.410320510 Disease-specific patterns of locus coeruleus cell loss
Neurobiol. Aging Gottfries 4 261 1983 10.1016/0197-4580(83)90002-7 Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT)
Neurosci. Lett. Harrison 200 151 1995 10.1016/0304-3940(95)12102-A The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins
Mol. Brain Res. Harrison 9 161 1991 10.1016/0169-328X(91)90143-L Terminal coma affects messenger RNA detection in postmortem human temporal cortex
Ann. Neurol. Hoogendijk 45 82 1999 10.1002/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T Increased activity of surviving locus ceruleus neurons in Alzheimer’s disease
Brain Res. Bull. Loughlin 9 287 1982 10.1016/0361-9230(82)90142-3 Locus coeruleus projections to cortex: topography, morphology and collateralizations
Br. J. Psychiatry Mann 136 533 1980 10.1192/bjp.136.6.533 Changes in the monoamine containing neurons of the human CNS in senile dementia
Neurobiol. Aging Mann 2 57 1981 10.1016/0197-4580(81)90060-9 Central amine metabolism in Alzheimer’s disease: in vivo relationship to cognitive deficit
Neurosci. Lett. Marcyniuk 64 247 1986 10.1016/0304-3940(86)90336-8 Loss of nerve cells from locus coeruleus in Alzheimer’s disease is topographically arranged
Neurology McKhann 34 939 1984 10.1212/WNL.34.7.939 Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer’s disease
Neurology Morris 48 1508 1997 10.1212/WNL.48.6.1508 Clinical dementia rating training and reliability in multicenter studies: the Alzheimer’s Disease Cooperative Study experience
Biochemistry O’Malley 26 6910 1987 10.1021/bi00396a007 Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs
Brain Res. Palmer 401 231 1987 10.1016/0006-8993(87)91408-9 Monoaminergic innervation of the frontal and temporal lobes in Alzheimer’s disease
J. Neurol. Sci. Perry 51 279 1981 10.1016/0022-510X(81)90106-4 Neuropathological and biochemical observations on the noradrenergic system in Alzheimer’s disease
Arch. Gen. Psychiatry Raskind 41 343 1984 10.1001/archpsyc.1984.01790150033006 Norepinephrine and MHPG levels in CSF and plasma in Alzheimer’s disease
J. Neurol. Sci. Reinikainen 84 101 1988 10.1016/0022-510X(88)90179-7 A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer’s disease
Exp. Brain Res. Sara 89 125 1992 10.1007/BF00229009 Noradrenergic hyperactivity after partial fornix section: role in cholinergic dependent memory performance
Mol. Brain Res. Szot 44 46 1997 10.1016/S0169-328X(96)00217-3 Effect of pentylenetetrazol on the expression of tyrosine hydroxylase mRNA and norepinephrine and dopamine transporter mRNA
Brain Res. Tejani-Butt 631 147 1993 10.1016/0006-8993(93)91201-3 Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer’s disease
J. Neurol. Transm. Park. Dis. Dement. Sect. Tohgi 4 69 1992 10.1007/BF02257623 Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger’s type
J. Neurol. Sci. Tomlinson 49 419 1981 10.1016/0022-510X(81)90031-9 Cell loss in the locus coeruleus in senile dementia of the Alzheimer type
J. Neurochem. Zhu 68 134 1997 10.1046/j.1471-4159.1997.68010134.x Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.